Delivery of biological agents by aerosols

被引：49

作者：

Edwards, DA ^{[1
]}

机构：

[1] Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA

[2] Alkermes Inc, Cambridge, MA 02139 USA

来源：

AICHE JOURNAL | 2002年 / 48卷 / 01期

关键词：

D O I：

10.1002/aic.690480102

中图分类号：

TQ [化学工业];

学科分类号：

0817 ;

摘要：

[No abstract available]

引用

页码：2 / 6

页数：5

共 36 条

[1]

ADJEI A, 2000, INHALATION DELIVERY

[2]

Ansel H. C., 1999, PHARM DOSAGE FORMS D, DOI DOI 10.1016/j.ijpharm.2006.03.010

[3] Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs [J].

Ben-Jebria, A ;

Chen, DH ;

Eskew, ML ;

Vanbever, R ;

Langer, R ;

Edwards, DA .

PHARMACEUTICAL RESEARCH, 1999, 16 (04) :555-561

[4] Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract [J].

Bot, AI ;

Tarara, TE ;

Smith, DJ ;

Bot, SR ;

Woods, CM ;

Weers, JG .

PHARMACEUTICAL RESEARCH, 2000, 17 (03) :275-283

[5] Dose-response relation of liquid aerosol inhaled insulin in Type I diabetic patients [J].

Brunner, GA ;

Balent, B ;

Ellmerer, M ;

Schaupp, L ;

Siebenhofer, A ;

Jendle, JH ;

Okikawa, J ;

Pieber, TR .

DIABETOLOGIA, 2001, 44 (03) :305-308

[6] MEDICAL AEROSOL INHALERS - PAST, PRESENT, AND FUTURE [J].

CLARK, AR .

AEROSOL SCIENCE AND TECHNOLOGY, 1995, 22 (04) :374-391

[7]

Davies CharlesNorman., 1973, Air filtration

[8]

De Young L. R., 1998, RESP DRUG DELIVERY, VVI, P91

[9] Hollow porous particles in metered dose inhalers [J].

Dellamary, LA ;

Tarara, TE ;

Smith, DJ ;

Woelk, CH ;

Adractas, A ;

Costello, ML ;

Gill, H ;

Weers, JG .

PHARMACEUTICAL RESEARCH, 2000, 17 (02) :168-174

[10]

DUNBAR C, 2000, EUR PHARM REV, V5, P48

← 1 2 3 4 →